AARTI DRUGS
Back to Balance Sheet
|
AARTI DRUGS Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹2,815 Cr | ₹2,575 Cr | ₹2,432 Cr | ₹2,421 Cr | ₹2,208 Cr |
What is the latest Total Liabilities ratio of AARTI DRUGS ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹2,815 Cr |
| Mar2025 | ₹2,575 Cr |
| Mar2024 | ₹2,432 Cr |
| Mar2023 | ₹2,421 Cr |
| Mar2022 | ₹2,208 Cr |
How is Total Liabilities of AARTI DRUGS Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,815 Cr | 9.34 | |
| Mar2025 | ₹2,575 Cr | 5.85 | |
| Mar2024 | ₹2,432 Cr | 0.45 | |
| Mar2023 | ₹2,421 Cr | 9.67 | |
| Mar2022 | ₹2,208 Cr | - | |
Compare Total Liabilities of peers of AARTI DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AARTI DRUGS | ₹3,559.8 Cr | -2.7% | -9.7% | -20.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,684.0 Cr | -0.2% | -4.9% | 5.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹242,904.0 Cr | 1.3% | -2.3% | 38.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹172,213.0 Cr | -1.5% | -5.8% | 29.3% | Stock Analytics | |
| CIPLA | ₹106,138.0 Cr | 0.1% | -4.2% | -14.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,304.0 Cr | 1.9% | 5.7% | 0.4% | Stock Analytics | |
AARTI DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AARTI DRUGS | -2.7% |
-9.7% |
-20.4% |
| SENSEX | 0.9% |
-0.8% |
-10.5% |
You may also like the below Video Courses